Patrick S. Bernard

827 total citations
19 papers, 721 citations indexed

About

Patrick S. Bernard is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Patrick S. Bernard has authored 19 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Patrick S. Bernard's work include Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (4 papers) and Chemical Synthesis and Analysis (3 papers). Patrick S. Bernard is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (4 papers) and Chemical Synthesis and Analysis (3 papers). Patrick S. Bernard collaborates with scholars based in Switzerland. Patrick S. Bernard's co-authors include D A Bennett, Gary Pastor, Jeffrey M. Liebman, Deborah E. Murphy, Naokata Yokoyama, Douglas E. Wilson, Jennifer Schneider, Douglas J. Steel, John Lehmann and Cindy Tsai and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Patrick S. Bernard

19 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick S. Bernard Switzerland 12 521 303 146 141 75 19 721
Carl A. Boast United States 19 768 1.5× 370 1.2× 99 0.7× 256 1.8× 75 1.0× 31 1.1k
B M Baron United States 15 767 1.5× 575 1.9× 162 1.1× 96 0.7× 127 1.7× 21 1.1k
Elisabetta Maciocco Italy 20 450 0.9× 244 0.8× 204 1.4× 128 0.9× 74 1.0× 41 957
H.‐R. Olpe Switzerland 12 573 1.1× 352 1.2× 145 1.0× 117 0.8× 253 3.4× 16 1.1k
William Billard United States 13 710 1.4× 640 2.1× 175 1.2× 86 0.6× 53 0.7× 24 1.1k
Ian A. Pullar United Kingdom 21 592 1.1× 469 1.5× 177 1.2× 95 0.7× 118 1.6× 38 1.1k
Carol J. Grossman United Kingdom 7 585 1.1× 475 1.6× 93 0.6× 71 0.5× 121 1.6× 8 1.0k
H Rosengarten United States 18 693 1.3× 488 1.6× 63 0.4× 85 0.6× 187 2.5× 34 1.2k
Petar Polc Switzerland 8 428 0.8× 206 0.7× 59 0.4× 132 0.9× 53 0.7× 8 497
Deborah K. Hyslop United States 12 515 1.0× 324 1.1× 93 0.6× 106 0.8× 122 1.6× 19 900

Countries citing papers authored by Patrick S. Bernard

Since Specialization
Citations

This map shows the geographic impact of Patrick S. Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick S. Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick S. Bernard more than expected).

Fields of papers citing papers by Patrick S. Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick S. Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick S. Bernard. The network helps show where Patrick S. Bernard may publish in the future.

Co-authorship network of co-authors of Patrick S. Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick S. Bernard. A scholar is included among the top collaborators of Patrick S. Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick S. Bernard. Patrick S. Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Francis, John E., William D. Cash, Patrick S. Bernard, et al.. (1991). Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones. Journal of Medicinal Chemistry. 34(1). 281–290. 62 indexed citations
2.
Bennett, D A, et al.. (1989). Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.. Journal of Pharmacology and Experimental Therapeutics. 250(2). 454–460. 64 indexed citations
3.
Hutchison, Alan, Michael Williams, Christof Angst, et al.. (1989). 4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors and anticonvulsant activity. Journal of Medicinal Chemistry. 32(9). 2171–2178. 63 indexed citations
4.
Bennett, Debra A., et al.. (1988). A comparison of PCP-like compounds for NMDA antagonism in two models. Life Sciences. 42(4). 447–454. 36 indexed citations
5.
Lehmann, John, Jennifer Schneider, Deborah E. Murphy, et al.. (1987). CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 240(3). 737–746. 217 indexed citations
6.
Bennett, Debra A., Douglas E. Wilson, Carl A. Boast, et al.. (1987). Pharmacological characterization of CGS 17867A as a benzodiazepine receptor agonist devoid of limiting behavioral effects. Drug Development Research. 11(3-4). 219–233. 10 indexed citations
7.
Bernard, Patrick S., Gary Pastor, & Jeffrey M. Liebman. (1986). CGS 8216, a benzodiazepine antagonist, reduces food intake in food-deprived rats. Pharmacology Biochemistry and Behavior. 24(6). 1703–1706. 13 indexed citations
8.
Bernard, Patrick S., D A Bennett, Gary Pastor, Naokata Yokoyama, & Jeffrey M. Liebman. (1985). CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.. Journal of Pharmacology and Experimental Therapeutics. 235(1). 98–105. 63 indexed citations
9.
Bennett, Debra A., et al.. (1985). Behavioral pharmacological profile of CGS 9895: A novel anxiomodulator with selective benzodiazepine agonist and antagonist properties. Drug Development Research. 6(4). 313–325. 32 indexed citations
10.
Petrack, Barbara, et al.. (1984). CGS 9896 AND CGS 8216. Clinical Neuropharmacology. 7. S361–S361. 4 indexed citations
11.
Liebman, Jeffrey M., Richard Lovell, Albert Braunwalder, et al.. (1983). CGS 7525A, A new, centrally active alpha2 adrenoceptor antagonist. Life Sciences. 32(4). 355–363. 15 indexed citations
12.
Boast, Carl A., et al.. (1983). The neuropharmacology of various diazepam antagonists. Neuropharmacology. 22(12). 1511–1521. 75 indexed citations
13.
Petrack, Barbara, et al.. (1983). Benzodiazepine receptor ligands with opposing pharmacologic actions.. PubMed. 38. 129–37. 21 indexed citations
14.
Liebman, Jeffrey M., Gary Pastor, Patrick S. Bernard, & Jeffrey K. Saelens. (1980). Antagonism of intrastriatal and intravenous kainic acid by 1-nuciferine: Comparison with various anticonvulsants and gabamimetics. Life Sciences. 27(21). 1991–1998. 4 indexed citations
15.
Saelens, Jeffrey K., Patrick S. Bernard, & Douglas E. Wilson. (1980). Baclofen as an analgesic. Brain Research Bulletin. 5. 553–557. 15 indexed citations
16.
Bernard, Patrick S., et al.. (1980). Antagonism of a kainic acid syndrome by baclofen and other putative GABAmimetics. Brain Research Bulletin. 5. 519–523. 9 indexed citations
17.
Bernard, Patrick S., et al.. (1979). Comparative neurological and anticonvulsant effects of baclofen (BF), muscimol (MC), diazepam (DZ) and γ-butyrolactone (GBL). Brain Research Bulletin. 4(5). 695–695. 1 indexed citations
18.
Bernard, Patrick S., et al.. (1972). Biochemical and behavioral modifications in septal and hypothalamically-lesioned rats. Neuropharmacology. 11(1). 39–44. 8 indexed citations
19.
Beattie, Craig W., et al.. (1969). Pharmacological alteration of hyper-reactivity in rats with septal and hypothalamic lesions. International Journal of Neuropharmacology. 8(4). 365–371. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl A. Boast Breakdown of academic impact, for papers by B M Baron Breakdown of academic impact, for papers by Elisabetta Maciocco Breakdown of academic impact, for papers by H.‐R. Olpe Breakdown of academic impact, for papers by William Billard Breakdown of academic impact, for papers by Ian A. Pullar Breakdown of academic impact, for papers by Carol J. Grossman Breakdown of academic impact, for papers by H Rosengarten Breakdown of academic impact, for papers by Petar Polc Breakdown of academic impact, for papers by Deborah K. Hyslop
Rankless by CCL
2026